SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General statement of acquisition of beneficial ownership:
SEC Accession No. 0001193125-13-361442
Filing Date
2013-09-09
Accepted
2013-09-09 16:15:32
Documents
1

Document Format Files

Seq Description Document Type Size
1 SC 13D d595343dsc13d.htm SC 13D 55842
  Complete submission text file 0001193125-13-361442.txt   57174
Mailing Address 3960 BROADWAY NEW YORK NY 10032
Business Address 3960 BROADWAY NEW YORK NY 10032 212-923-3344
Intra-Cellular Therapies, Inc. (Subject) CIK: 0001567514 (see all company filings)

IRS No.: 364742850 | State of Incorp.: DE | Fiscal Year End: 0331
Type: SC 13D | Act: 34 | File No.: 005-87380 | Film No.: 131085822
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O TAG ASSOCIATES 75 ROCKEFELLER PLAZA, 9TH FLOOR NEW YORK NY 10019
Business Address
Greengard Paul (Filed by) CIK: 0001585671 (see all company filings)

Type: SC 13D